Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Finished Goods: 2019-2024

Historic Finished Goods for Ptc Therapeutics (PTCT) over the last 6 years, with Dec 2024 value amounting to $8.4 million.

  • Ptc Therapeutics' Finished Goods rose 1.46% to $8.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.6 million, marking a year-over-year increase of 1.46%. This contributed to the annual value of $8.4 million for FY2024, which is 27.45% down from last year.
  • As of FY2024, Ptc Therapeutics' Finished Goods stood at $8.4 million, which was down 27.45% from $11.6 million recorded in FY2023.
  • Ptc Therapeutics' Finished Goods' 5-year high stood at $11.6 million during FY2023, with a 5-year trough of $6.7 million in FY2022.
  • Over the past 3 years, Ptc Therapeutics' median Finished Goods value was $8.4 million (recorded in 2024), while the average stood at $8.9 million.
  • In the last 5 years, Ptc Therapeutics' Finished Goods skyrocketed by 74.79% in 2023 and then dropped by 27.45% in 2024.
  • Over the past 5 years, Ptc Therapeutics' Finished Goods (Yearly) stood at $9.1 million in 2020, then fell by 26.41% to $6.7 million in 2021, then fell by 0.91% to $6.7 million in 2022, then spiked by 74.79% to $11.6 million in 2023, then fell by 27.45% to $8.4 million in 2024.